Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 5, 2004, Pages 516-521

  Lustig, Robert A ^a,d   Scott, Charles B ^b   Curran, Walter J ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b RADIATION THERAPY ONCOLOGY GROUP   (United States)

^c THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain tumor; Glioblastoma; Stereotactic radiosurgery

Indexed keywords

CARMUSTINE;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; OUTCOMES RESEARCH; PATIENT SELECTION; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIOSURGERY; RANDOMIZED CONTROLLED TRIAL; RECURSIVE PARTITIONING ANALYSIS; SCORING SYSTEM; STATISTICAL ANALYSIS; STEREOTAXIC SURGERY; SURVIVAL RATE; TECHNIQUE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RADIOSURGERY; RANDOMIZED CONTROLLED TRIALS; SELECTION BIAS; SURVIVAL ANALYSIS;

EID: 5644293143     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000135641.82026.c4     Document Type: Article

References (16)

1. Seiferheld W, Mehta M, DelRowe, et al. Five years of glioblastoma multiforme (GBM) phase II trials at the Radiation Therapy Oncology Group (RTOG). Proceeding from American Society of Clinical Oncology (ASCO), Orlando, FL. J Clin Oncol. 2001; p. 71, Abstract 283.
2. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011-1018.
3. Bernstein M, Laperriere N, Glen J, et al. Brachytherapy for recurrent malignant astrocytoma. Int J Radiat Oncol Biol Phys. 1994;30:1213-1217.
4. CBTRUS. Statistical Report: Primary Brain Tumors in the United States 1992-1997. Central Brain Tumor Registry of the United States; 2000:24-25.
5. Souhami L, Scott C, Brachman D, et al. Randomized prospective comparison of stereotactic radiosurgery (SRS) followed by conventional radiotherapy (RT) with BCNU to RT with BCNU alone for selected patients with supratentorial glioblastoma multiforme (GBM) report of RTOG 93-05 Protocol. Proceedings of the American Society of Therapeutic Radiation Oncology (ASTRO); New Orleans, LA. Int J Radiat Oncol Biol Phys. 2002;54:2; 94-95; Abstract 158.
6. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG Protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47:291-298.
7. Curran W, Scott C, Horton J, et al. Recursive partitioning analysis of prognostic factors in three radiation therapy oncology. Group Malignant Glioma Trials. J Natl Cancer Inst. 1993;85:704-710.
8. Curran W, Scott C, Yung W, et al. No survival benefit of hyperfractionated radiotherapy (RT) to 72.0 Gy & carmustine versus standard RT & carmustine for malignant glioma patients: preliminary results of RTOG 90-06. Proceedings of the American Society Clinical Oncology (ASCO), Philadelphia, PA. Proc Am Soc Clin Oncol (ASCO). 1996;15: 154; Abstract.
9. Scott CB, Nelson JS, Farnan NC, et al. Central pathology review in clinical trials for patients with malignant gliomas: a report of radiation therapy oncology group 83-02. Cancer. 1995;76:307-313.
10. StarXact 3 for Windows, CYTEL Software; 1996.
11. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
12. Masciopinto JE, Levin AB, Mehta MP, et al. Stereotactic radiosurgery for glioblastoma: a final report of 31 patients. J Neurosurg. 1995;82:530-535.
13. Sakaria JN, Mehta MP, Loeffleer, et al. Radiosurgery in the initial management of gliomas: survival comparison with the RTOG recursive partitioning analysis. Int J Radiat Oncol Biol Phys. 1995;32:931-941.
14. Mehta MP, Masciopinto J, Rozental J, et al. Stereotactic radiosurgery for glioblastoma: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Biol Phys. 1994;30:541-549.
15. Shenoouda G, Souhami L, Podgorask EB, et al. Radiosurgery and accelerated radiosurgery for patients with glioblastoma. Can J Neurol Sci. 1997;24:110-115.
16. Shrieve DC, Alexander E III, Black PM, et al. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome. J Neurosurg. 1999;90:72-77.